Australia's Optiscan rises after imaging more than 80 cases in ACL study
10/09/2026 02:40
BUZZ-Australia's Optiscan rises after imaging more than 80 cases in ACL study ** Shares of Australia's Optiscan Imaging OIL.AX rise as much as 10% to A$0.165, their biggest intraday pct gain since August 19
** Shares hit their highest levels since August 27
** The medical technology firm says it has imaged more than 80 cases in a study with Australian Clinical Labs (ACL) using its InForm digital pathology imaging device
** Company says study uses InForm device for real-time, slide-free cellular imaging at point of contact, in real-world pathology environment
** Optiscan stock up 60%, YTD
(Reporting by Subhalakshmi Dey in Bengaluru)
Recent news on X2M Connect
See all newsAustralia's X2M Connect jumps on $175 million data centre project deal
Brief: X2M Connect Signs Binding Agreement To Deliver AI-Enabled Data Centre
Brief: X2M Connect Enters Non-Binding MoU With Gateway DC For Data Centre Campuses In Darwin
Brief: X2M Connect Signs Third Partnership Agreement For High Density Gpu Data Centres
Australia's Optiscan rises after imaging more than 80 cases in ACL study